SEPARATION AND GENERAL RELEASE AGREEMENTSeparation and General Release Agreement • May 4th, 2020 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 4th, 2020 Company Industry JurisdictionThis SEPARATION AND GENERAL RELEASE AGREEMENT (the “Agreement”) is made and entered into this 30th day of April, 2020, between Innovate Biopharmaceuticals, Inc. (name to change to 9 Meters Biopharma, Inc., immediately after the Closing (as defined below)), a Delaware corporation (the “Company”), and Sandeep Laumas, MD (“Executive”). Throughout the remainder of the Agreement, the Company and Executive may be collectively referred to as “the parties.”
SEPARATION AND GENERAL RELEASE AGREEMENTSeparation and General Release Agreement • May 4th, 2020 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 4th, 2020 Company Industry JurisdictionThis SEPARATION AND GENERAL RELEASE AGREEMENT (the “Agreement”) is made and entered into this 30th day of April, 2020, between Innovate Biopharmaceuticals, Inc. (name to change to 9 Meters Biopharma, Inc., immediately after the Closing (as defined below)), a Delaware corporation (the “Company”), and Jay P. Madan (“Executive”). Throughout the remainder of the Agreement, the Company and Executive may be collectively referred to as “the parties.”